Apo-Meprobamate en es it fr

Apo-Meprobamate Brand names, Apo-Meprobamate Analogs

Apo-Meprobamate Brand Names Mixture

  • No information avaliable

Apo-Meprobamate Chemical_Formula


Apo-Meprobamate RX_link

No information avaliable

Apo-Meprobamate fda sheet

Apo-Meprobamate msds (material safety sheet)

Apo-Meprobamate Synthesis Reference

No information avaliable

Apo-Meprobamate Molecular Weight

309.469 g/mol

Apo-Meprobamate Melting Point

< 25 oC

Apo-Meprobamate H2O Solubility

Soluble as HCl salt

Apo-Meprobamate State


Apo-Meprobamate LogP


Apo-Meprobamate Dosage Forms

Tablets (oral, 1 mg)

Apo-Meprobamate Indication

Used for the symptomatic treatment of parkinsonism.

Apo-Meprobamate Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Apo-Meprobamate Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Apo-Meprobamate side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Apo-Meprobamate Patient Information

Apo-Meprobamate Organisms Affected

Humans and other mammals